Prosecution Insights
Last updated: April 19, 2026
Application No. 18/269,285

CUSHIONING MEMBER AND SOLE FOR SHOE

Final Rejection §103
Filed
Jun 22, 2023
Examiner
TAUFIQ, FARAH N
Art Unit
1754
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Asics Corporation
OA Round
4 (Final)
62%
Grant Probability
Moderate
5-6
OA Rounds
3y 2m
To Grant
89%
With Interview

Examiner Intelligence

Grants 62% of resolved cases
62%
Career Allow Rate
163 granted / 264 resolved
-3.3% vs TC avg
Strong +27% interview lift
Without
With
+27.0%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
58 currently pending
Career history
322
Total Applications
across all art units

Statute-Specific Performance

§101
2.5%
-37.5% vs TC avg
§103
54.6%
+14.6% vs TC avg
§102
19.2%
-20.8% vs TC avg
§112
18.9%
-21.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 264 resolved cases

Office Action

§103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment Claim 1 is currently amended, claims 2, 4, and 12-13 are previously presented, claim 3 is original, claims 5-11 and 14-18 are withdrawn, and claims 19-20 are new. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claim(s) 1-4, and 12-13 is/are rejected under 35 U.S.C. 103 as being unpatentable over Yamada (US2013/0143029 A1) in view of Maeda (JP2019/166644 A). Regarding claim 1, Yamada discloses a production method of producing a cushioning member for a shoe, comprising a foamed area and a non-foamed area, the method comprising: filling a mold [0001] with a first foamable material that is unfoamed and a second non-foamable (4) material [0014, 0018], the first unfoamed foamable (4) material comprising an elastomer [0071] and a foaming agent [0077], and the second non-foamable material (3) not having foaming properties [0077] (the first unfoamed foamable layer is foamed after injection into the mold (“wherein upon injection of the non-foaming and foaming polyurethane resins into the closed mold cavity, the non-foaming polyurethane resin forms a non-foamed skin layer and the foaming polyurethane resin forms a foamed layer” (claim 11)) ; and molding the first unfoamed foamable material and the second non-foamable material the foamed area being formed with the first foamable material by foaming the first foamable material after the mold has been filled with the first foamable material [0018], and the non-foamed area being formed by the second non-foamable material [0078] the first unfoamed foamable layer is foamed after injection into the mold (“wherein upon injection of the non-foaming and foaming polyurethane resins into the closed mold cavity, the non-foaming polyurethane resin forms a non-foamed skin layer and the foaming polyurethane resin forms a foamed layer” (claim 11)). As for the cushioning member for a shoe, a recitation of the intended use of the claimed invention must result in a structural difference between the claimed invention and the prior art in order to patentably distinguish the claimed invention from the prior art. If the prior art structure is capable of performing the intended use, then it meets the claim. As for the limitation, molding the first foamable material and the second non-foamable material by heating and cooling the first foamamble material and the second non-foamable material together after the mold has been filled with the first foamable material and the second non-foamable material, analogous art, Maeda, discloses heating a cooling the first foamamble and second non-foamable material together after the mold is filled (pg. 3 paragraphs 9-10 and comparative examples). Therefore, it would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to have , molding the first foamable material and the second non-foamable material by heating and cooling the first foamamble material and the second non-foamable material together after the mold has been filled with the first foamable material and the second non-foamable material in order to the targeted viscosity of the material based on design needs of the final product [0019]. Regarding claim 2, Yamada discloses wherein the first foamable material comprises a thermoplastic elastomer and a foaming agent [0043]. Regarding claim 3, Yamada discloses wherein the foaming agent is a chemical foaming or an expanding foaming agent [0043]. Regarding claims 4 and 12-13, Yamada discloses wherein the second non-foamable material comprises a thermoplastic elastomer [0044]. Claim(s) 19-20 is/are rejected under 35 U.S.C. 103 as being unpatentable over Yamada (US2013/0143029 A1) in view of Maeda (JP2019/166644 A), as applied to claim 1, and further in view of Otsuka (US 2015/0181975 A1). Regarding claim 19, Yamada does not explicitly discloses wherein the first foamable material is filled in the mold in at least one of particle form and plate-like form. However, analogous foamed art, Otsuka, discloses at least one of particle form [0100] and plate-like form [0045]. Therefore, it would have been obvious to one having ordinary skill in the art to have disposed the foamable material in particle form and plate-like form since MPEP 2144.04 states It has been held that a mere change in shape without affecting the functioning of the part would have been within the level of ordinary skill in the art, In re Dailey et al., 149 USPQ 47; Eskimo Pie Corp. v, Levous et aI., 3 USPQ 23. Regarding claim 20, Yamada does not explicitly discloses the second non-foamable material is filled in the mold in particle form. However, MPEP 2144.04 states It has been held that a mere change in shape without affecting the functioning of the part would have been within the level of ordinary skill in the art, In re Dailey et al., 149 USPQ 47; Eskimo Pie Corp. v, Levous et aI., 3 USPQ 23. Therefore, it would have been obvious to one having ordinary skill in the art to have disposed the foamable material in particle form and plate-like form since MPEP 2144.04 states It has been held that a mere change in shape without affecting the functioning of the part would have been within the level of ordinary skill in the art, In re Dailey et al., 149 USPQ 47; Eskimo Pie Corp. v, Levous et aI., 3 USPQ 23. Response to Arguments Applicant's arguments filed 10/30/2025 have been fully considered but they are not persuasive. Applicant argues Maeda taches already foamed material. However, Yamada teaches the first unfoamed foamable layer is foamed after injection into the mold (“wherein upon injection of the non-foaming and foaming polyurethane resins into the closed mold cavity, the non-foaming polyurethane resin forms a non-foamed skin layer and the foaming polyurethane resin forms a foamed layer” (claim 11)). One ordinary skilled in the art would understand claim 11 implies the foamed layer is formed after injection. Applicant argues Maeda doesn’t teach the unfoamed foamable layer. However, the office has relied on Yamada for the teaching of the unfoamed foamable layer (claim 11). Applicant further argues Yamada fails to teach the heating and cooling of the materials together. However, the office relied on the analogous art, Maeda, to show how conventional it is to heat and cool the material together. Further is it conventional known in molding that in order for the material to cure, it has to be heated and then cooled. In response to applicant's arguments against the references individually, one cannot show nonobviousness by attacking references individually where the rejections are based on combinations of references. See In re Keller, 642 F.2d 413, 208 USPQ 871 (CCPA 1981); In re Merck & Co., 800 F.2d 1091, 231 USPQ 375 (Fed. Cir. 1986). It is the combination of Yamada and Maeda that read on the claim limitation. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure: DE4390938C3 discloses injecting the mold with a foamable thermoplastic elastomer that foams up after the injection (claim 1) and therefore has a foamable and a non-foamable layer. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to FARAH N TAUFIQ whose telephone number is (571)272-6765. The examiner can normally be reached Monday-Friday: 8:00 am-4:30 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Susan Leong can be reached at (571)270-1487. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /FARAH TAUFIQ/ Primary Examiner, Art Unit 1754
Read full office action

Prosecution Timeline

Jun 22, 2023
Application Filed
Feb 07, 2025
Non-Final Rejection — §103
Apr 15, 2025
Applicant Interview (Telephonic)
Apr 15, 2025
Examiner Interview Summary
Apr 30, 2025
Response Filed
May 21, 2025
Final Rejection — §103
Jul 18, 2025
Response after Non-Final Action
Jul 21, 2025
Examiner Interview (Telephonic)
Aug 06, 2025
Request for Continued Examination
Aug 12, 2025
Response after Non-Final Action
Aug 21, 2025
Non-Final Rejection — §103
Oct 30, 2025
Response Filed
Jan 12, 2026
Final Rejection — §103
Apr 09, 2026
Applicant Interview (Telephonic)
Apr 10, 2026
Examiner Interview Summary

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12594603
HEATING/COOLING OF A PROCESS CHAMBER OF A MANUFACTURING DEVICE FOR ADDITIVE MANUFACTURING OF THREE-DIMENSIONAL COMPONENTS
2y 5m to grant Granted Apr 07, 2026
Patent 12594699
METHOD FOR PRODUCING POLYPROPYLENE-BASED RESIN EXPANDED BEADS
2y 5m to grant Granted Apr 07, 2026
Patent 12589550
PCD EXTRUSION NOZZLE
2y 5m to grant Granted Mar 31, 2026
Patent 12576608
METHOD OF MANUFACTURING A TUNABLE MIDSOLE FOR AN ARTICLE OF FOOTWEAR
2y 5m to grant Granted Mar 17, 2026
Patent 12570050
METHOD OF USING A PRINT HEAD ASSEMBLY FOR EXTRUSION-BASED ADDITIVE CONSTRUCTION
2y 5m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

5-6
Expected OA Rounds
62%
Grant Probability
89%
With Interview (+27.0%)
3y 2m
Median Time to Grant
High
PTA Risk
Based on 264 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month